|

ITI-1284 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 2

Top Sponsors

  • Intra-Cellular Therapies, Inc.2

Indications

  • Alzheimer's Disease2
  • Agitation Associated With Alzheimer's Dementia1
  • Psychosis Associated With Alzheimer's Disease1

Anaheim, California2 trials

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

Clinical Site

Phase 2
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Clinical Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.